TLR4 and autoimmune polyendocrinopathy: In APS, there is no known NOD activation, but TLR1, 2, 4 and 6 are activated [150,151] resulting in TLR2-TLR4 and TLR4-TLR6 synergies (Figure 7, Table 2).